Compare Dr. Reddys with Fulford India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. REDDYS LAB vs FULFORD INDIA - Comparison Results

DR. REDDYS LAB     Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the pharmaceutical value chain - basic research, finished dosages, generics, bulk actives, and biotechnology. The company's business is mainly organized into Global g... More

FULFORD INDIA 
   Change

Fulford (India) Limited is an Indian affiliate of Schering-Plough Corporation, USA. The company has presence in oncology, virology and cardiovascular segments. In FY06 the topline of the company grew by 15.5% to Rs. 1519 m from Rs. 1279 m in FY05. PA... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. REDDYS LAB FULFORD INDIA DR. REDDYS LAB/
FULFORD INDIA
 
P/E (TTM) x 39.4 398.8 9.9% View Chart
P/BV x 5.4 6.2 86.8% View Chart
Dividend Yield % 0.5 0.1 581.2%  

Financials

 DR. REDDYS LAB   FULFORD INDIA
EQUITY SHARE DATA
    DR. REDDYS LAB
Mar-20
FULFORD INDIA
Mar-14
DR. REDDYS LAB/
FULFORD INDIA
5-Yr Chart
Click to enlarge
High Rs3,363942 357.0%   
Low Rs2,352450 522.7%   
Sales per share (Unadj.) Rs1,054.2691.4 152.5%  
Earnings per share (Unadj.) Rs121.911.5 1,063.8%  
Cash flow per share (Unadj.) Rs190.215.4 1,238.5%  
Dividends per share (Unadj.) Rs25.002.00 1,250.0%  
Dividend yield (eoy) %0.90.3 304.5%  
Book value per share (Unadj.) Rs938.7380.0 247.0%  
Shares outstanding (eoy) m166.173.90 4,260.8%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x2.71.0 269.3%   
Avg P/E ratio x23.460.7 38.6%  
P/CF ratio (eoy) x15.045.3 33.2%  
Price / Book Value ratio x3.01.8 166.2%  
Dividend payout %20.517.4 117.5%   
Avg Mkt Cap Rs m474,8312,714 17,493.0%   
No. of employees `00021.70.4 4,876.1%   
Total wages/salary Rs m33,802505 6,693.5%   
Avg. sales/employee Rs Th8,091.06,073.0 133.2%   
Avg. wages/employee Rs Th1,561.31,137.4 137.3%   
Avg. net profit/employee Rs Th935.8100.7 929.5%   
INCOME DATA
Net Sales Rs m175,1702,696 6,496.4%  
Other income Rs m6,206125 4,949.0%   
Total revenues Rs m181,3762,822 6,427.7%   
Gross profit Rs m24,421-46 -52,631.5%  
Depreciation Rs m11,34815 74,657.9%   
Interest Rs m98310 10,347.4%   
Profit before tax Rs m18,29654 33,694.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m5610-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-1,40310 -14,614.6%   
Profit after tax Rs m20,26045 45,324.4%  
Gross profit margin %13.9-1.7 -810.2%  
Effective tax rate %-7.717.7 -43.4%   
Net profit margin %11.61.7 697.7%  
BALANCE SHEET DATA
Current assets Rs m125,9911,738 7,247.9%   
Current liabilities Rs m72,141545 13,244.2%   
Net working cap to sales %30.744.3 69.4%  
Current ratio x1.73.2 54.7%  
Inventory Days Days7348 150.8%  
Debtors Days Days1054 2,433.7%  
Net fixed assets Rs m83,85412 704,655.5%   
Share capital Rs m83139 2,130.8%   
"Free" reserves Rs m155,1571,443 10,752.4%   
Net worth Rs m155,9881,482 10,525.5%   
Long term debt Rs m1,3040-   
Total assets Rs m232,2532,077 11,183.8%  
Interest coverage x19.66.7 292.0%   
Debt to equity ratio x00-  
Sales to assets ratio x0.81.3 58.1%   
Return on assets %9.12.6 350.5%  
Return on equity %13.03.0 430.6%  
Return on capital %12.64.3 293.0%  
Exports to sales %00-   
Imports to sales %024.5 0.0%   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNA659 0.0%   
Fx inflow Rs m84,19317 489,494.2%   
Fx outflow Rs m39,616673 5,885.1%   
Net fx Rs m44,577-656 -6,795.7%   
CASH FLOW
From Operations Rs m29,84190 33,156.7%  
From Investments Rs m-4,923105 -4,706.5%  
From Financial Activity Rs m-25,159-14 178,432.6%  
Net Cashflow Rs m-266181 -147.4%  

Share Holding

Indian Promoters % 25.5 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 5.4 3.8 142.1%  
FIIs % 35.3 0.1 35,300.0%  
ADR/GDR % 18.5 0.0 -  
Free float % 15.3 21.2 72.2%  
Shareholders   75,885 4,783 1,586.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. REDDYS LAB With:   ELDER PHARMA  FDC  SHASUN PHARMA  DISHMAN PHARMA  J.B.CHEMICALS  

Compare DR. REDDYS LAB With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 202 Points Lower; Britannia and Mahindra & Mahindra Among Top Nifty Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Related Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

Top 3 Nifty ETFs to Buy Now(Fast Profits Daily)

Apr 20, 2021

In this video I tell you the three Nifty ETFs I think are the best.

A Stock with 700% Return Potential Comes with Additional Payoffs(Profit Hunter)

Apr 15, 2021

Narayana Murthy was one of the first unicorn founders to get the backing of this entity...

11x Bankruptcy to Bluechip Stock: A Rare India Revival Story(Profit Hunter)

Apr 16, 2021

There is no stopping this 11-bagger stock from significant upside.

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. REDDYS LAB SHARE PRICE


Apr 23, 2021 03:37 PM

TRACK DR. REDDYS LAB

  • Track your investment in DR. REDDYS LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

DR. REDDYS LAB - JUBILANT PHARMOVA COMPARISON

COMPARE DR. REDDYS LAB WITH

MARKET STATS